Showing 2061-2070 of 3102 results for "".
- Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc.https://modernaesthetics.com/news/elevai-labs-inc-announces-anticipated-name-change-to-pmgc-holdings-inc/2473721/Elevai Labs Inc. is changing its name to PMGC Holdings Inc., the company announced Friday. A press release also stated that PMGC Holdings Inc. plans to effectuate a strategic reorganization effective on Dec. 20. Along with the name change, the reorganization includes moving from D
- Recent Wall Street Journal Article “Belittles” Efforts of Dermatologists, Dr. Doris Dayhttps://modernaesthetics.com/news/recent-wall-street-journal-article-belittles-efforts-of-dermatologists-dr-doris-day/2473719/Modern Aesthetics Editorial Board member Doris Day, MD, FAAD, didn’t hold back when speaking out against a recent Wall Street Journal article portraying dermatology as a cushiony specialty and citing that as a reason it is gaining increasing traction from me
- FDA Clears Illuminate PRP System for Clinical Usehttps://modernaesthetics.com/news/fda-clears-illuminate-prp-system-for-clinical-use/2473718/Illuminate PRP’s platelet-rich plasma (PRP) system has received FDA clearance for clinical use, the company announced. The FDA-cleared single-spin PRP system offers a fast, efficient method for preparing high-quality PRP with high platelet capture rates, providing physicians with
- Aesthetics Tech Forum Returns January 9-10https://modernaesthetics.com/news/aesthetics-tech-forum-returns-january-9-10/2473717/Modern Aesthetics executive editor Kay Durairaj, MD, FACS, emeritus founding chief medical editor Steve H. Dayan, MD, FACS, and various other editorial board members and contributors will present at the 2025 Aesthetics Tech Forum, powered by Octane, on January 9-10 in Newport Beach, Cali
- Study: PLLA-SCA Induces Adipogenesis and Volumization of the Hip Dellhttps://modernaesthetics.com/news/study-plla-sca-induces-adipogenesis-and-volumization-of-the-hip-dell/2473709/Injecting poly-l-lactic acid (PLLA-SCA) is a safe and effective method for durable volumization and aesthetic improvement of the hip dell, and may promote adipogenesis and elastogenesis, according to a new study published in Dermatologic Surgery. &ldq
- Dr. Patrick J. Byrne Named Next President of AAFPRShttps://modernaesthetics.com/news/dr-patrick-j-byrne-named-next-president-of-aafprs/2473707/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) announced Patrick J. Byrne, MD, MBA, as president for the 2024-2025 term year. Dr. Byrne, an Ohio-based facial plastic and reconstructive surgeon, formally assumed his new role at the 2024 AAFPRS Annual Business Meeting in
- ASDS Abstract Examines Black Women’s Aesthetic Concernshttps://modernaesthetics.com/news/asds-abstract-examines-black-womens-aesthetic-concerns/2473705/Patients’ concerns and desires can vary based on various demographics, so understanding the interests of Black women was the focus of a top-10 abstract presented by Michelle Henry, MD, at the 2024 American Society for Dermatologic Surgery (ASDS) Annual Meeting. Dr. Henry presented
- ASDS Abstract Highlights Potential of ALA-PDThttps://modernaesthetics.com/news/asds-abstract-highlights-potential-of-ala-pdt/2473704/Photodynamic therapy (PDT) with aminolevulonic acid (ALA) was the topic of the top 10 abstract “Fine Wrinkles and the Art of Light,” presented by Luke Horton, MD, at the 2024 American Society for Dermatologic Surgery (ASDS) Annual Meeting. Dr. Horton performed a study along
- DefenAge Skincare Launches 12-Factor Revitalizing Lip Enhancerhttps://modernaesthetics.com/news/defenage-skincare-launches-12-factor-revitalizing-lip-enhancer/2473701/DefenAge Skincare introduces a “revolutionary, first-of-its kind” anti-aging serum for fuller, smoother and more youthful lips. The 12-Factor Revitalizing Lip Enhancer is powered by DefenAge’s patented Age-Repair Defensins. The lip serum is designed to rejuvenate lip a
- Study Backs CP-GEP Tests’ Accuracyhttps://modernaesthetics.com/news/study-backs-cp-gep-tests-accuracy/2473699/Patients with clinically node-negative primary cutaneous melanoma undergoing sentinel lymph node biopsies (SLNBs) who were classified as “high risk” according to CP-GEP tests were approximately three times more likely to be SLN positive, according to data presented October 13 at the S